A study to analyse whether the type of glaucoma and combination of drugs affect the periocular changes.
Not Applicable
Completed
- Registration Number
- CTRI/2018/04/012949
- Lead Sponsor
- Giridhar Eye Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 32
Inclusion Criteria
All patients on prostaglandin analogues for less than 6 months irrespective of glaucoma or combination of drugs used.
Exclusion Criteria
(a) Patients who has undergone any surgery other than cataract surgery (b) patients already detected with ocular surface diseases (c) patients having lid diseases like ptosis, thyroid related orbitopathy or lid tumours.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method (a) Study orbital changes in patients on PGA by photographic documentation (b) Study ocular surface changes in patients on PGA by clinical examination pre and post 6 months.Timepoint: 12 months
- Secondary Outcome Measures
Name Time Method Comparative study will be done to assess the changes in various parameters and statistical analysis will be done.Timepoint: 12 months